Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral etrasimod is a safe and effective
treatment for moderately active ulcerative colitis in adult participants.